Glanbia poised for growth through American acquisition

Glanbia is buoyant after another year of strong growth and can make more moves in the growing performance nutrition market, writes Michael Murray.

Recipe for success Siobhan Talbot, Glanbia managing director, and Mark Garvey, financial director. Picture: Jason Clarke Photography

CytoSport, the US-based sports nutrition business, remains a potential takeover target for Glanbia as the bidding process for the US company remains a work in progress.

Following its results announcement last week Glanbia group managing director Siobhán Talbot said that any decision to raise new equity would be ''event driven. This followed reports - in circulation since last summer - that the performance nutrition and ingredients group is on a shortlist of potential ...